adalimumab IBD
Selected indexed studies
- Biosimilars of adalimumab: the upcoming challenge in IBD. (Expert Opin Biol Ther, 2019) [PMID:30601098]
- Efficacy and safety of infliximab and adalimumab in inflammatory bowel disease patients. (Inflammopharmacology, 2024) [PMID:38985232]
- Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study. (Gut, 2018) [PMID:28119352]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Biosimilars of adalimumab: the upcoming challenge in IBD. (2019) pubmed
- Efficacy and safety of infliximab and adalimumab in inflammatory bowel disease patients. (2024) pubmed
- Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study. (2018) pubmed
- Belgian IBD Research Group [BIRD] Position Statement 2019 on the Use of Adalimumab Biosimilars in Inflammatory Bowel Diseases. (2020) pubmed
- Efficacy of Biologic Drugs in Short-Duration Versus Long-Duration Inflammatory Bowel Disease: A Systematic Review and an Individual-Patient Data Meta-Analysis of Randomized Controlled Trials. (2022) pubmed
- Development of Extramusculoskeletal Manifestations in Upadacitinib-Treated Patients With Psoriatic Arthritis or Axial Spondyloarthritis. (2025) pubmed
- Do Not Stop Anti-TNF Medications in Children With IBD When They Are Working. (2022) pubmed
- A randomised, crossover trial exploring the patient perspective and effectiveness of biosimilar adalimumab transition: IBD reference and biosimilar adalimumab cross over study (iBaSS). (2024) pubmed
- No Difference of Adalimumab Pharmacokinetics When Dosed at 40 mg Every Week or 80 mg Every Other Week in IBD Patients in Clinical Remission After Adalimumab Dose Intensification. (2021) pubmed
- Safety of infliximab and adalimumab in pediatric inflammatory bowel diseases: a disproportionality analysis from the FAERS database. (2025) pubmed